Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas

Aaron M. Bender, Lara S. Collier, Fausto J. Rodriguez, Christina Tieu, Jon D. Larson, Chandralekha Halder, Eric Mahlum, Thomas M. Kollmeyer, Keiko Akagi, Gobinda Sarkar, David A. Largaespada, Robert B. Jenkins

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


The Sleeping Beauty (SB) transposon system has been used as an insertional mutagenesis tool to identify novel cancer genes. To identify glioma-associated genes, we evaluated tumor formation in the brain tissue from 117 transgenic mice that had undergone constitutive SB-mediated transposition. Upon analysis, 21 samples (18%) contained neoplastic tissue with features of high-grade astrocytomas. These tumors expressed glial markers and were histologically similar to human glioma. Genomic DNA from SB-induced astrocytoma tissue was extracted and transposon insertion sites were identified. Insertions in the growth factor gene Csf1 were found in 13 of the 21 tumors (62%), clustered in introns 5 and 8. Using reverse transcription-PCR, we documented increased Csf1 RNAs in tumor versus adjacent normal tissue, with the identification of transposon-terminated Csf1 mRNAs in astrocytomas with SB insertions in intron 8. Analysis of human glioblastomas revealed increased levels of Csf1 RNA and protein. Together, these results indicate that SB-insertional mutagenesis can identify high-grade astrocytoma-associated genes and they imply an important role for CSF1 in the development of these tumors.

Original languageEnglish (US)
Pages (from-to)3557-3565
Number of pages9
JournalCancer Research
Issue number9
StatePublished - May 1 2010


Dive into the research topics of 'Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas'. Together they form a unique fingerprint.

Cite this